SS-31
Mitochondrial
Also known as: Elamipretide, Bendavia, MTP-131
A cell-permeable peptide that targets cardiolipin in the inner mitochondrial membrane to reduce oxidative damage.
- Dose in studies
- 10-40 mg per day
- Frequency
- Daily
- Cycle length
- 4-12 weeks based on indication
- Half-life
- 1-2 hours
- Research level
- 3/5 – Moderate research
Frequently asked questions about SS-31
What is SS-31?
A cell-permeable peptide that targets cardiolipin in the inner mitochondrial membrane to reduce oxidative damage.
What is the half-life of SS-31?
The half-life of SS-31 is 1-2 hours.
What dosage of SS-31 has been studied?
Described in research: 10-40 mg per day, frequency: Daily. This is not a medical recommendation.
How long is a SS-31 cycle?
Typical cycle length in studies: 4-12 weeks based on indication.
What are the side effects of SS-31?
Injection site reactions: Mild redness and soreness at injection site. Standard subcutaneous injection side effect. Rotate sites regularly. · Mild fatigue: Temporary tiredness during initial mitochondrial adaptation. Usually resolves within the first week. · Headache: Occasional mild headaches. Adequate hydration recommended. · GI discomfort: Mild nausea or stomach upset. More common with higher…
How well researched is SS-31?
Moderate research (3/5). Several controlled human studies or approval in a niche indication; evidence still patchy.